Main Menu

Our funding partners

The Institute of Cancer Research works closely with a number of funding and research organisations, including Cancer Research UKBreast Cancer Now and Wellcome.

We also have a close partnership with The Royal Marsden NHS Foundation Trust, allowing effective translation of scientific results into new treatments for patients.

Cancer Research UK and Cancer Research Technology

A large proportion of the work at the ICR is supported by Cancer Research UK – the UK’s largest cancer research charity. Where Cancer Research UK is the main external sponsor, their technology transfer company, Cancer Research Technology Ltd (CRT) will be involved in determining the best route for commercial exploitation and identifying suitable collaborators and may lead on negotiations. The Enterprise Unit works closely with CRT to ensure that the exploitation strategy matches the ICR’s mission.

View partner website

Breast Cancer Now

The Breast Cancer Research Centre at the ICR is supported by Breast Cancer Now and brings together 140 doctors and scientists to carry out research into the causes and treatment of breast cancer. Any IP generated through joint ICR-Breast Cancer Now projects will be owned jointly by ICR and Breast Cancer Now. It is managed by the Enterprise Unit and any benefits shared.

View partner website

The Wellcome Trust

The Wellcome Trust is a charitable research foundation dedicated to achieving improvements in human health. The Wellcome Trust funds a number of major research programmes at the ICR including three Seeding Drug Discovery Initiative Awards. IP generated from Wellcome Trust projects is owned by the ICR.

Commercial interactions may be led by either the Enterprise Unit or the Wellcome Trust but the Enterprise Unit plays an active role in all projects, from the preparation of applications to the subsequent exploitation of the results.

View partner website

The Royal Marsden NHS Foundation Trust

The ICR works closely with our clinical partner, The Royal Marsden NHS Foundation Trust – a world-leading cancer centre specialising in cancer diagnosis, treatment, research and education. Together, we form the largest comprehensive cancer centre in Europe. Through this partnership, we undertake ground-breaking research into new cancer drug therapies and treatments. Any IP generated through joint ICR-Royal Marsden projects is managed by the Enterprise Unit and any benefits shared.

View partner website
We use cookies to ensure that we give you the best experience on our website. By continuing to use this website, you are agreeing to our use of cookies on your device as described in our cookie policy. You can change your cookie settings at any time but parts of our site will not function correctly without them.